BDBM614794 5-[({1-[2-Fluoro- 4- (trifluoromethoxy) phenyl]cyclopro- pyl}carbonyl) amino]-2-{1-[(1- methylcyclo- propyl) methyl]-1H-yl}benzoic acid::US20230271931, Example 152

SMILES CC1(Cn2cc(cn2)-c2ccc(NC(=O)C3(CC3)c3ccc(OC(F)(F)F)cc3F)cc2C(O)=O)CC1

InChI Key InChIKey=JBZNXDFGGMRXDA-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 614794   

TargetB1 bradykinin receptor(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM614794(US20230271931, Example 152 | 5-[({1-[2-Fluoro- 4- ...)
Affinity DataIC50: 8.10nMAssay Description:Notably, Compound Examples are tested in the FLIPR assays in the absence (hB1 free IC50) of 0.1% BSA in assay buffer, in order to assess the potency ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/15/2023
Entry Details
Go to US Patent